• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 15, 2021 at 12:32: PM
via Eli Lilly and Company and Banner Alzheimer’s Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional d

article source
 




Top Bottom
Back
Quote